Autoimmune Polyendocrine Syndromes.

Autoimmune Polyendocrine Syndromes Autoimmune polyendocrine syndromes comprise a diverse group of clinical entities involving functional impairment of multiple endocrine glands due to loss of immune tolerance. This article reviews recent discoveries as well as approaches to the care of affected patients.

[1]  Matthew D. Hellmann,et al.  Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade , 2018, The New England journal of medicine.

[2]  F. Rieux-Laucat,et al.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study , 2017, The Journal of allergy and clinical immunology.

[3]  Mark S. Anderson,et al.  Dominant-negative loss of function arises from a second, more frequent variant within the SAND domain of autoimmune regulator (AIRE). , 2017, Journal of autoimmunity.

[4]  P. Knappskog,et al.  Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1 , 2017, The Journal of clinical endocrinology and metabolism.

[5]  E. Adams,et al.  Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen , 2017, Immunity.

[6]  Mark S. Anderson,et al.  Exome Sequencing Reveals Mutations in AIRE as a Cause of Isolated Hypoparathyroidism , 2017, The Journal of clinical endocrinology and metabolism.

[7]  M. Gutierrez,et al.  Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome , 2017, Front. Immunol..

[8]  P. Dahlqvist,et al.  Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study , 2016, The Journal of clinical endocrinology and metabolism.

[9]  E. Husebye,et al.  AIRE-mutations and autoimmune disease. , 2016, Current opinion in immunology.

[10]  K. Lindblad-Toh,et al.  Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's disease , 2016, Journal of internal medicine.

[11]  P. Lorigan,et al.  Hyponatraemia secondary to nivolumab-induced primary adrenal failure , 2016, Endocrinology, diabetes & metabolism case reports.

[12]  H. Kong,et al.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. , 2016, JCI insight.

[13]  S. Corsello,et al.  Endocrinological side-effects of immune checkpoint inhibitors , 2016, Current opinion in oncology.

[14]  J. Svartberg,et al.  A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1 , 2016, The Journal of clinical endocrinology and metabolism.

[15]  Jeffrey A. Bluestone,et al.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.

[16]  J. B. Oliveira,et al.  Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. , 2015, The Journal of clinical investigation.

[17]  O. Dekkers,et al.  European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. , 2015, European journal of endocrinology.

[18]  J. Hughes,et al.  Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy , 2015, Science.

[19]  Mark S. Anderson,et al.  Transglutaminase 4 as a prostate autoantigen in male subfertility , 2015, Science Translational Medicine.

[20]  W. Newman,et al.  Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases. , 2015, Immunity.

[21]  S. Gettinger,et al.  Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy , 2015, Diabetes Care.

[22]  Elisha D O Roberson,et al.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.

[23]  A. Schäffer,et al.  Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations , 2014, Nature Medicine.

[24]  N. Gilhus,et al.  Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen Transcripts in Their Tumors , 2014, The Journal of Immunology.

[25]  J. B. Oliveira,et al.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 , 2014, Science.

[26]  J. Kere,et al.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease , 2014, Nature Genetics.

[27]  E. Bosi,et al.  Autoantibodies to Harmonin and Villin Are Diagnostic Markers in Children with IPEX Syndrome , 2013, PloS one.

[28]  Mark S. Anderson,et al.  BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease , 2013, Science Translational Medicine.

[29]  Mark S. Anderson,et al.  Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. , 2013, Cell stem cell.

[30]  Nicholas D. Socci,et al.  Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells , 2013, Science.

[31]  R. Deterding,et al.  Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab , 2012, Pediatric pulmonology.

[32]  J. Wagner,et al.  Generation and Large‐Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft‐Versus‐Host Disease , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  J. Weill,et al.  Autoimmune Polyendocrine Syndrome Type 1 in North-Western France: AIRE Gene Mutation Specificities and Severe Forms Needing Immunosuppressive Therapies , 2010, Hormone Research in Paediatrics.

[34]  F. Cetani,et al.  Abbreviations used: AD, , 2022 .

[35]  A. Fischer,et al.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2010, The Journal of experimental medicine.

[36]  Roger Holder,et al.  Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. , 2010, The American journal of medicine.

[37]  N. Ives,et al.  Acquired Autoimmune Polyglandular Syndrome, Thymoma, and an AIRE Defect , 2010 .

[38]  J. Carlson,et al.  Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. , 2009, The Journal of clinical endocrinology and metabolism.

[39]  J. Perheentupa,et al.  Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I , 2009, Journal of internal medicine.

[40]  C. Janson,et al.  Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen , 2009, Proceedings of the National Academy of Sciences.

[41]  Joseph T. Glessner,et al.  Follow-Up Analysis of Genome-Wide Association Data Identifies Novel Loci for Type 1 Diabetes , 2009, Diabetes.

[42]  U. Pollak,et al.  Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1 , 2009, European Journal of Pediatrics.

[43]  O. Kämpe,et al.  Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency , 2008, Clinical endocrinology.

[44]  Howard Y. Chang,et al.  Deletional Tolerance Mediated by Extrathymic Aire-Expressing Cells , 2008, Science.

[45]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[46]  L. Peltonen,et al.  Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. , 2008, The New England journal of medicine.

[47]  Mark Atkinson,et al.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes , 2007, Nature Genetics.

[48]  A. Caudy,et al.  CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. , 2007, The Journal of allergy and clinical immunology.

[49]  J. Bollerslev,et al.  Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. , 2007, The Journal of clinical endocrinology and metabolism.

[50]  M. Dominguez,et al.  Ocular complications of autoimmune polyendocrinopathy syndrome type 1. , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[51]  J. Perheentupa.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. , 2006, The Journal of clinical endocrinology and metabolism.

[52]  P. Peterson,et al.  Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1 , 2006, PLoS medicine.

[53]  S. Rosenberg,et al.  Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. , 2005, Journal of immunotherapy.

[54]  M. Simmonds,et al.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA‐4 and beyond , 2004, Clinical and experimental immunology.

[55]  Nunzio Bottini,et al.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.

[56]  M. Manns,et al.  Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. , 2004, The Journal of clinical endocrinology and metabolism.

[57]  G. Eisenbarth,et al.  Autoimmune polyendocrine syndromes , 2004 .

[58]  Luc J. Smink,et al.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.

[59]  Mark S. Anderson,et al.  Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.

[60]  A. Filipovich,et al.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2002, Journal of medical genetics.

[61]  L. Peltonen,et al.  AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. , 2002, The Journal of clinical endocrinology and metabolism.

[62]  C. Marcocci,et al.  A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. , 2001, The Journal of clinical endocrinology and metabolism.

[63]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[64]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[65]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[66]  E. Seidman,et al.  Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. , 1999, The Journal of clinical endocrinology and metabolism.

[67]  J. Haavik,et al.  Identification of tryptophan hydroxylase as an intestinal autoantigen , 1998, The Lancet.

[68]  L. Peltonen,et al.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.

[69]  Shinsei Minoshima,et al.  Positional cloning of the APECED gene , 1997, Nature Genetics.

[70]  W. Klitz,et al.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. , 1996, American journal of human genetics.

[71]  O. Kämpe,et al.  21-hydroxylase, a major autoantigen in idiopathic Addison's disease , 1992, The Lancet.

[72]  J. Perheentupa,et al.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. , 1990, The New England journal of medicine.

[73]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[74]  E. Thorsby,et al.  Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer , 1989, The Journal of experimental medicine.

[75]  B. Czarnocka,et al.  Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases , 1985, FEBS letters.

[76]  B. Powell,et al.  An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. , 1982, The Journal of pediatrics.